Last reviewed · How we verify

NCT03891004

Skin Closure With Tissue Adhesives vs. Subcuticular Suture After Robotic Urogynecologic Procedures

Completed NA Last updated 4 April 2019
What this trial tests

NA trial testing Subcuticular Skin Closure in Surgical Wound in 47 participants. Completed in 31 December 2018.

Timeline
20 March 2018
Primary endpoint
31 December 2018
31 December 2018

Quick facts

Lead sponsorSt. John Hospital & Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment47
Start date20 March 2018
Primary completion31 December 2018
Estimated completion31 December 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

St. John Hospital & Medical Center

Who can join

Adults 18 to 99, female only, with Surgical Wound or Tissue Adhesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare skin closure via subcuticular suture versus tissue adhesive (Dermabond) in urogynecological robotic surgeries. The primary outcome is incision cosmesis at the 12 week follow up visit. Secondary outcome is the operative time between the two methods of closure.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Randomized clinical trial comparing skin closure with tissue adhesives <i>vs</i> subcuticular suture after robotic urogynecologic procedures.
    Fluellen S, Mackey K, Hagglund K, Aslam MF. · · 2020 · cited 4× · PMID 33194565 · DOI 10.5662/wjm.v10.i1.1

Verify or expand the search:

Other recruiting trials for Surgical Wound

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03891004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing